Skyscape Web Viewer : TNM Cancer Staging Manual : Image Index

View All
pN1b is defined as clinically apparent and /or radiologically detected regional lymph node metastasis
pN1 is defined as one-two unilateral inguinal metastases, no extra nodal extension
pN2 is defined as three or more unilateral metastases or bilateral metastases
pN3 is defined as extra nodal extension of lymph node metastases or pelvic lymph node metastases
Post-neoadjuvant therapy stage (ypTNM) and overall survival in patients who underwent surgical resection and were given chemotherapy and /or radiation therapy before surgery, stratified by ypStage groupings, based on NCDB data (2004-2008; median follow-up, 23 months; n = 683)
Primary sites of the paranasal sinuses
Probability of survival according to mutation status
Recurrence-free and overall survival for patients treated with 1 versus 3 years of imatinib for higher-risk GIST, defined as having at least one of the following features: (1) longest tumor diameter greater than 10
Regional lymph nodes for NETs of the colon and rectum
Regional lymph nodes for skin sites of the head and neck
Regional lymph nodes for the cervix uteri
Regional lymph nodes for the vagina
Regional lymph nodes of ovary, fallopian tube and primary peritoneal carcinomas
Regional lymph nodes of the adrenal gland
Regional lymph nodes of the anal canal
Regional lymph nodes of the corpus uteri
Regional lymph nodes of the duodenum and ampulla of Vater
Regional lymph nodes of the kidney
Regional lymph nodes of the pancreas (anterior view)
Regional lymph nodes of the penis
Regional lymph nodes of the pleura
Regional lymph nodes of the stomach
Regional lymph nodes of the urethra
Regional lymph nodes of the vulva
Regional percent of body surface area in the adult (From Olsen et al
Relative Age Adjusted Incidence of Brain Tumors (from Ostrom et al
Relative survival of colon and rectal carcinoma patients in the SEER database since the TNM 7th Edition was introduced in January 2010
Risk-adjusted survival after treatment decision for clinically staged (c) adenocarcinoma of the esophagus based on WECC data
Risk-adjusted survival after treatment decision for clinically staged (c) squamous cell carcinoma of the esophagus based on Worldwide Esophageal Cancer Collaboration (WECC) data
Risk-adjusted survival after treatment decision for pathologically staged (p) adenocarcinoma of the esophagus based on WECC data

NDX